Mochida submits escitalopram NDA in Japan

Mochida Pharmaceutical Co. Ltd. (Tokyo:4534) submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for escitalopram to treat depression. Mochida has Japanese development and commercialization rights to escitalopram from H. Lundbeck A/S (CSE:LUN). Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508) has co-marketing rights in Japan to the allosteric serotonin reuptake inhibitor (SSRI). ...